Walleye Trading
EBS icon

Walleye Trading’s Emergent Biosolutions EBS Stock Holding History

Walleye Trading’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,000
Closed -$44.7K – 4475
2025
Q2 		$44.7K Buy
+7,000
New +$40.1K ﹤0.01% 3838
2023
Q4 		– Sell
-8,800
Closed -$29.9K – 5159
2023
Q3 		$29.9K Sell
8,800
-31,800
-78% -$176K ﹤0.01% 4319
2023
Q2 		$298K Buy
+40,600
New +$376K ﹤0.01% 3152
2022
Q4 		– Sell
-14,100
Closed -$296K – 5065
2022
Q3 		$296K Buy
+14,100
New +$392K ﹤0.01% 3383
2015
Q2 		– Sell
-3,500
Closed -$101K – 4898
2015
Q1 		$101K Buy
+3,500
New +$100K ﹤0.01% 2657

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Walleye Trading's EBS Position: Q4 2023 in Review

Walleye Trading sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 1,620 shares — an estimated $5.51K sold.

Walleye Trading first reported a position in EBS in Q2 2015 and held it in 9 quarters. The position peaked at $692K in Q2 2016. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Walleye Trading reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 1,620 Emergent Biosolutions shares in Q4 2023, an estimated $5.51K.
  • Walleye Trading first reported a position in Emergent Biosolutions in Q2 2015 and held it in 9 quarters.
  • Walleye Trading's Emergent Biosolutions position peaked at $692K in Q2 2016.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.